| 04/15/2026 3:03 PM | KALA BIO (1479419) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 4:40 PM | KALA BIO (1479419) Subject Rosen Howard B (1307068) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 8:16 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 11:15 PM | KALA BIO (1479419) Filer | Form EFFECT | |
| 02/09/2026 3:15 PM | Berger Chaim D. (2110273) Reporting KALA BIO (1479419) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/09/2026 3:15 PM | Colman Yonatan C. (2110255) Reporting KALA BIO (1479419) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/09/2026 3:15 PM | KALA BIO (1479419) Issuer Minkowitz Avraham (2110204) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/09/2026 3:16 PM | KALA BIO (1479419) Issuer Posen Hillel D. (2109561) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/09/2026 3:16 PM | KALA BIO (1479419) Issuer Purdy Brendan P. (2110412) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/06/2026 3:14 PM | KALA BIO (1479419) Subject Lazar David E. (1932843) Filed by | Form SCHEDULE 13D | |
| 02/02/2026 5:01 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KALA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter.
|
| 01/26/2026 3:05 PM | KALA BIO (1479419) Filer | Form DEFA14A | |
| 01/23/2026 3:05 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 7:00 AM | KALA BIO (1479419) Subject LIFESCI CAPITAL, LLC (1580446) Filed by | Form SCHEDULE 13G | |
| 01/08/2026 3:05 PM | KALA BIO (1479419) Filer | Form 424B5 | |
| 01/08/2026 3:07 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 3:05 PM | KALA BIO (1479419) Filer | Form DEFA14A | |
| 01/06/2026 6:30 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 3:15 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/30/2025 3:12 PM | KALA BIO (1479419) Filer | Form DEF 14A | |
| 12/29/2025 3:52 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 4:18 PM | KALA BIO (1479419) Issuer Lazar David E. (1932843) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 4:18 PM | KALA BIO (1479419) Filer | Form PRER14A | |
| 12/16/2025 12:28 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/16/2025 8:32 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 3:05 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 5:00 AM | KALA BIO (1479419) Filer | Form 424B5 | |
| 12/03/2025 3:51 PM | KALA BIO (1479419) Subject OXFORD FINANCE LLC (1556257) Filed by | Form SCHEDULE 13G | |
| 12/03/2025 4:00 PM | KALA BIO (1479419) Issuer OXFORD FINANCE LLC (1556257) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 12/02/2025 5:30 AM | KALA BIO (1479419) Issuer Lazar David E. (1932843) Reporting | Form 3/A | |
| 11/26/2025 1:50 PM | KALA BIO (1479419) Issuer Lazar David E. (1932843) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 11/26/2025 2:03 PM | KALA BIO (1479419) Issuer Lazar David E. (1932843) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 3:15 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/19/2025 6:26 AM | KALA BIO (1479419) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/14/2025 12:07 PM | Cormorant Asset Management, LP (1583977) Filed by KALA BIO (1479419) Subject | Form SCHEDULE 13G/A | |
| 11/10/2025 7:00 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 7:00 PM | KALA BIO (1479419) Issuer Kharabi Darius (1893729) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 7:00 PM | Brazzell Romulus K (1298079) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 7:00 PM | Bazemore Todd (1605767) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 7:00 PM | KALA BIO (1479419) Issuer Reumuth Mary (1710969) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 7:00 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 10/23/2025 6:03 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/23/2025 3:02 PM | KALA BIO (1479419) Subject Reumuth Mary (1710969) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/22/2025 6:07 PM | KALA BIO (1479419) Subject Reumuth Mary (1710969) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/22/2025 5:21 PM | Brazzell Romulus K (1298079) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/22/2025 5:08 PM | Bazemore Todd (1605767) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/22/2025 4:10 PM | KALA BIO (1479419) Subject Kharabi Darius (1893729) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/20/2025 7:00 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2025 5:24 PM | KALA BIO (1479419) Subject SR ONE CAPITAL MANAGEMENT, LLC (1853723) Filed by | Form SCHEDULE 13D/A | |
| 10/03/2025 8:06 AM | BAKER BROS. ADVISORS LP (1263508) Filed by KALA BIO (1479419) Subject | Form SCHEDULE 13G | |
| 10/02/2025 7:37 PM | BAKER BROS. ADVISORS LP (1263508) Filed by KALA BIO (1479419) Subject | Form SCHEDULE 13D/A | |
| 10/02/2025 3:47 PM | Baker Bros. Advisors (0) GP BAKER BROS. ADVISORS LP (1263508) Reporting BAKER FELIX (1087940) Reporting BAKER JULIAN (1087939) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2025 6:31 PM | KALA BIO (1479419) Subject SR ONE CAPITAL MANAGEMENT, LLC (1853723) Filed by | Form SCHEDULE 13D/A | |
| 10/01/2025 7:00 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2025 7:08 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2025 3:24 PM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 4:28 PM | KALA BIO (1479419) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G | |
| 09/11/2025 3:02 PM | KALA BIO (1479419) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G | |
| 09/02/2025 3:08 PM | Bazemore Todd (1605767) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2025 7:08 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 7:01 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 7:06 AM | KALA BIO (1479419) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/09/2025 7:08 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2025 7:00 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 7:00 PM | Brazzell Romulus K (1298079) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 7:00 PM | Bazemore Todd (1605767) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 7:00 PM | KALA BIO (1479419) Issuer Reumuth Mary (1710969) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 7:00 PM | KALA BIO (1479419) Issuer Kharabi Darius (1893729) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 7:00 PM | KALA BIO (1479419) Subject Kharabi Darius (1893729) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2025 7:00 PM | KALA BIO (1479419) Subject Reumuth Mary (1710969) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2025 7:01 PM | Brazzell Romulus K (1298079) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2025 7:01 PM | Bazemore Todd (1605767) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2025 7:02 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/17/2025 7:00 PM | KALA BIO (1479419) Issuer KOVEN ANDREW I (1258673) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:00 PM | KALA BIO (1479419) Issuer Myers C. Daniel (1489533) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:00 PM | KALA BIO (1479419) Issuer PERRY GREGORY D (1236371) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:00 PM | Farid Marjan (1952098) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:00 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:00 PM | KALA BIO (1479419) Issuer Rosen Howard B (1307068) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 8:44 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Issuer | Form 4/A | |
| 06/04/2025 7:00 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 7:00 PM | Brazzell Romulus K (1298079) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 7:00 PM | Bazemore Todd (1605767) Reporting KALA BIO (1479419) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 7:00 PM | KALA BIO (1479419) Issuer Reumuth Mary (1710969) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 7:00 PM | KALA BIO (1479419) Issuer Kharabi Darius (1893729) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 7:10 PM | Iwicki Mark T (1415537) Reporting KALA BIO (1479419) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/14/2025 7:01 AM | KALA BIO (1479419) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |